Active portfolio companies

Daptiv eProject was founded in the summer of 1997 as the innovator of the online project management model. With the vision of offering organizations increased efficiency and higher project ROI, eProject created next-generation digital workspaces where executives, project managers and project teams could effectively collaborate to drive project success. Based in Seattle, Washington, privately held eProject has used its unique position in the marketplace and a grassroots approach to develop an extensive customer base built on referrals and customer adoption.   eProject Announces $8.0 Million Financing Led by Kennet Venture Partners

Kuros Biosurgery Kuros Biosurgery was founded in March 2002 as a spin-off from the Swiss Federal Institute, ETHZ, and University of Zurich. The company is focused on developing novel therapies for biosurgery, tissue repair and regeneration. The three main development projects in bone augmentation as well as bone and skin regeneration are in late preclinical stages. The company was able to close collaboration agreements with Baxter Healthcare for the further development of products in the regeneration of bone and skin, and with Straumann in the field of dental applications.   Baxter and Kuros Announce Product License and Collaboration Agreement   Kuros Biosurgery AG secures option for CHF 6.1m (€ 4m) for a Second Financing Ro   Kuros Biosurgery

Neocutis SA Neocutis SA is a privately held company originated in 2003 from the University Hospital (CHUV) of the Lausanne Medical School. Neocutis mission is to provide innovative topical preparations for dermatological and gynaecological affections as well as high-end cosmeceutical skincare products dispensed exclusively by physicians.   Neocutis SA

Nexx Systems Process solutions for advanced packaging products, opto-electronics and telecommunications markets.   Completion of Series C Financing   NEXX Systems Announces Completion of Series B Financing   Nexx Systems

Novalar Pharmaceuticals Novalar is a specialty pharmaceutical company dedicated to developing and marketing novel healthcare solutions in the dental market.   Novalar Pharmaceuticals Raises $27 Million in Series C Financing

Novimmune S.A. Development of new therapies for auto-immune diseases and immuno-suppression.   Novimmune S.A.

Exits

Actelion Actelion a leading cardiovascular biotech company which markets Tracleer for pulmonary arterial hypertension (PAH). www.actelion.com.Actelion was quoted on the Swiss New Market Stock Exchange in April 2000 (symbol: ATLN) and is now trading on the Swiss main stock market.   Actelion initiates Phase IIb/III program with clazosentan   Actelion announces half-year results 2004   Actelion 9 month 2003 results   Actelion

Articulate Systems Voice command and recognition solution. Sold to Fonix (FONX) in July 1998.

Astex Astex is the world leader in fragment-based drug discovery - the most important advance in drug discovery chemistry in the last 20 years.

Axovan Drug discovery focused on a family of receptors responsible for cell communication, the G protein-coupled receptors. Acquired by Actelion in September 2003 for CHF60 - 250 million based on milestones.   Positive results from a Phase II European clinical study of clazosentan.   Axovan

Calera Optical Character Recognition (OCR). Sold to Caere (US) in December 1994. Caere subsequently merged with Scansoft then Nuance.

Dolphin Interconnect Solutions High performance interconnection bus. Sold participation in November 1996.

Endoart Medical technology company with a device to treat morbid obese patients. A gastric band restricts food intake, and is remotely controlled by the medical doctor. Company sold to Allergan (AGN) in February 2007.

Globe Span Virata GlobeSpanVirata, Inc. is a worldwide developer of advanced digital subscriber line (DSL) integrated circuits which enable high-speed data transmission over the existing network of copper telephone wires known as the local loop. Virata was quoted on the NASDAQ Stock Market in November 1999 and then merged with GlobeSpan Inc. in December 2001. It is now traded under the symbol GSPN. in November 1999, then merged with GlobSpan Inc. in December 2001, which then merged with Conexant Systems in November 2003 in a stock-deal worth $969.5 million   Conexant, GlobespanVirata to Merge

Lysis Acquired by Kudelski in May 2001. Lysis provides software solutions for creating, managing and delivering digital television services.   Lysis

M7 M7 development software enables fast creation of web applications. M7 was purchased by BEA.   BEA Takes Aggressive Step to Further Leadership in Developer Tools Market; Acqui

Makemusic! MakeMusic ! Provides musicians and the music publishing industry with digital solutions, allowing for secure downloads of digital sheet music files. Quoted on Nasdaq (Code MMUS).   Makemusic

MathSoft Technical calculation software for applying mathematics to engineering. Nasdaq IPO in February 1993.

Maxtor Maxtor is a leading manufacturer of hard drives, external drives and portable drives.(Nasdaq: MXTR)

Native Networks Optical and Metro Ethernet access solutions for telecom operators. Native was purchased by Alcatel.   EXIT: Alcatel to acquire Native Networks   Native to showcase EMX3700 at Supercomm 2004

Noise Cancellation Technologies Noice cancellation solution. Nasdaq IPO (NCTI) in October 1998.

Paion GmbH Biopharmaceutical company dedicated to the development of innovative therapeutic products for the treatment of strokes.   Fourth financing round closed   PAION: Desmoteplase study in stroke completed   Paion

Sandisk Corporation Flash memory semiconductor and products. Nasdaq IPO in November 1995.

SCM Microsystems SCM Microsystems is a leading supplier of solutions in the digital TV and authentication markets. SCM went public on the Nasdaq in November 1997 (SCMM) and is also traded on the Prime Standard of the Frankfurt exchange (SMY).   SCM Microsystems

Thommen Medical AG Thommen Medical AG was established in August 2001 in Waldenburg, Switzerland, and is engaged in the design, manufacture and distribution of products for dental implantology.   SPI® System Japan Launch Celebrated in Tokyo   Thommen Medical closes financing of CHF 14.0 million

Trintech Transaction reconciliation software and payment infrastructure solutions. Nasdaq IPO in Spetember 1999.

Copyright ? by Genevest All Right Reserved.